Daiichi Sankyo is a global pharmaceutical company with corporate origins in Japan, providing innovative products and services in 29 countries/regions around the world. With more than 120 years of scientific expertise, the company draws upon a rich legacy of innovation and a robust pipeline of promising new medicines to help patients. Through the outstanding knowledge and commitment of 17,000 + employees worldwide, Daiichi-Sankyo create innovative new and generic medicines, and new methods of drug discovery and delivery – sharing a passion for innovation, as well as compassion for the patients around the world who are in need of our medicines.
Tackling the Climate and Nature Emergency Will Require Politicians to Work Across Party Lines in the 21st Century
Chair of the Environment APPG, Alistair Strathern MP, writes for Chamber UK on the importance of working with partners across political parties, to create consensus, tackle climate change and renew ambition and action for climate and environmental leadership
